Wellcome Connecting Science | Multi–omics in Metabolic Disease
Wellcome Genome Campus, Hinxton, CB10 1RQ, UK and virtual
Web Address
https://coursesandconferences.wellcomeconnectingscience.org/event/multi-omics-in-metabolic-disease-20230607/
Registration
Deadline: 30/05/2023
Click here to register
General Information
The vast burden of non-communicable diseases facing the world today is diet-related. This includes obesity, type 2 diabetes, dyslipidemia, and a whole host of other related metabolic disorders. Although the prevalence is related to lifestyle, it is clear there are powerful genetic and other biological influences informing susceptibility to these conditions, which are inherently systemic disorders.
Great strides have been made in illuminating the complex pathophysiology of metabolic diseases, in large part due to the development and application of a whole repertoire of so-called ‘omics’ technologies. These include GWAS and genomics, epigenomics, transcriptomics, proteomics, metabolomics and lipidomics.
This meeting will gather international leaders in the field to update on the use of these ‘multi-omics’ approaches. It further aims to improve inter-disciplinary knowledge-dissemination between scientists and clinicians working in basic and therapeutic research.
The programme will include short oral presentations selected from abstracts, lightning talks, posters, discussion sessions and networking opportunities for a highly interactive meeting.
‘Image copyright © Polygraph Design / BIH@Charité’
Deadline for submissions: 28 March 2023
Meeting organisers:
Wellcome Connecting Science
conferences@wellcomeconnectingscience.org
Speakers:
Karen Mohlke – University of North Carolina, USA
Eran Segal- Weizmann Institute of Science, Israel
Simon Anderson – University of West indies, West Indies
Melina Claussnitzer – Broad Institute, USA
Karine Clement – Sorbonne Univeristy, France
Segun Fatumo – Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Uganda
Matthias Mann – Max Planck Institute of Biochemistry, Germany
Eric Fauman – Pfizer, USA
Anna Gloyn – Stanford University, USA
Joanna Howson – Novo Nordisk Research Centre Oxford, UK
Anna Krook- Stanford University, USA
Jessica Lasky-Su – Harvard University, USA
Markus Ralser – Berlin Institute of Health at Charite, Germany
Tune Pers – University of Copenhagen, Denmark
